Literature DB >> 25779574

agr dysfunction affects staphylococcal cassette chromosome mec type-dependent clinical outcomes in methicillin-resistant Staphylococcus aureus bacteremia.

Chang Kyung Kang1, Jeong Eun Cho2, Yoon Jeong Choi2, Younghee Jung1, Nak-Hyun Kim3, Chung-Jong Kim1, Taek Soo Kim4, Kyoung-Ho Song1, Pyoeng Gyun Choe3, Wan Beom Park3, Ji-Hwan Bang3, Eu Suk Kim1, Kyoung Un Park4, Sang Won Park3, Nam-Joong Kim3, Myoung-Don Oh3, Hong Bin Kim5.   

Abstract

Staphylococcal cassette chromosome mec element (SCCmec) type-dependent clinical outcomes may vary due to geographical variation in the presence of virulence determinants. We compared the microbiological factors and mortality attributed to methicillin-resistant Staphylococcus aureus (MRSA) bacteremia between SCCmec types II/III and type IV. All episodes of MRSA bacteremia in a tertiary-care hospital (South Korea) over a 4.5-year period were reviewed. We studied the microbiological factors associated with all blood MRSA isolates, including spa type, agr type, agr dysfunction, and the genes for Panton-Valentine leukocidin (PVL) and phenol-soluble modulin (PSM)-mec, in addition to SCCmec type. Of 195 cases, 137 involved SCCmec types II/III, and 58 involved type IV. The mortality attributed to MRSA bacteremia was less frequent among the SCCmec type IV (5/58) than that among types II/III (39/137, P = 0.002). This difference remained significant when adjusted for clinical factors (adjusted odds ratio [aOR], 0.14; 95% confidence interval [CI], 0.04 to 0.49; P = 0.002). Of the microbiological factors tested, agr dysfunction was the only significant factor that showed different positivity between the SCCmec types, and it was independently associated with MRSA bacteremia-attributed mortality (aOR, 4.71; 95% CI, 1.72 to 12.92; P = 0.003). SCCmec type IV is associated with lower MRSA bacteremia-attributed mortality than are types II/III, which might be explained by the high rate of agr dysfunction in SCCmec types II/III in South Korea.
Copyright © 2015, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25779574      PMCID: PMC4432210          DOI: 10.1128/AAC.04962-14

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  47 in total

1.  Risk factors for mortality of nosocomial methicillin-resistant Staphylococcus aureus (MRSA) bloodstream infection: with investigation of the potential role of community-associated MRSA strains.

Authors:  Jann-Tay Wang; Jiun-Ling Wang; Chi-Tai Fang; Wei-Chu Chie; Mei-Shu Lai; Tsai-Ling Lauderdale; Chia-Min Weng; Shan-Chwen Chang
Journal:  J Infect       Date:  2010-09-25       Impact factor: 6.072

2.  Predictive factors for mortality in patients with methicillin-resistant Staphylococcus aureus bloodstream infection: impact on outcome of host, microorganism and therapy.

Authors:  O Gasch; M Camoez; M A Dominguez; B Padilla; V Pintado; B Almirante; J Molina; F Lopez-Medrano; E Ruiz; J A Martinez; E Bereciartua; F Rodriguez-Lopez; C Fernandez-Mazarrasa; M A Goenaga; N Benito; J Rodriguez-Baño; E Espejo; M Pujol
Journal:  Clin Microbiol Infect       Date:  2013-01-17       Impact factor: 8.067

3.  Association of methicillin-resistant Staphylococcus aureus (MRSA) USA300 genotype with mortality in MRSA bacteremia.

Authors:  Russell R Kempker; Monica M Farley; Janine L Ladson; Sarah Satola; Susan M Ray
Journal:  J Infect       Date:  2010-09-22       Impact factor: 6.072

4.  Increased mortality with accessory gene regulator (agr) dysfunction in Staphylococcus aureus among bacteremic patients.

Authors:  Marin L Schweizer; Jon P Furuno; George Sakoulas; J Kristie Johnson; Anthony D Harris; Michelle D Shardell; Jessina C McGregor; Kerri A Thom; Eli N Perencevich
Journal:  Antimicrob Agents Chemother       Date:  2010-12-20       Impact factor: 5.191

5.  Area under the concentration-time curve to minimum inhibitory concentration ratio as a predictor of vancomycin treatment outcome in methicillin-resistant Staphylococcus aureus bacteraemia.

Authors:  Younghee Jung; Kyoung-Ho Song; Jeong eun Cho; Hyung-sook Kim; Nak-Hyun Kim; Taek Soo Kim; Pyoeng Gyun Choe; Jae-Yong Chung; Wan Beom Park; Ji Hwan Bang; Eu Suk Kim; Kyoung Un Park; Sang-Won Park; Hong Bin Kim; Nam Joong Kim; Myoung-don Oh
Journal:  Int J Antimicrob Agents       Date:  2013-11-18       Impact factor: 5.283

Review 6.  Association between vancomycin minimum inhibitory concentration and mortality among patients with Staphylococcus aureus bloodstream infections: a systematic review and meta-analysis.

Authors:  Andre C Kalil; Trevor C Van Schooneveld; Paul D Fey; Mark E Rupp
Journal:  JAMA       Date:  2014-10-15       Impact factor: 56.272

7.  Bacterial competition for human nasal cavity colonization: role of Staphylococcal agr alleles.

Authors:  Gerard Lina; Florent Boutite; Anne Tristan; Michèle Bes; Jerome Etienne; Francois Vandenesch
Journal:  Appl Environ Microbiol       Date:  2003-01       Impact factor: 4.792

Review 8.  Community-associated MRSA: what makes them special?

Authors:  Michael Otto
Journal:  Int J Med Microbiol       Date:  2013-03-19       Impact factor: 3.473

9.  Mobile genetic element SCCmec-encoded psm-mec RNA suppresses translation of agrA and attenuates MRSA virulence.

Authors:  Chikara Kaito; Yuki Saito; Mariko Ikuo; Yosuke Omae; Han Mao; Gentaro Nagano; Tomoko Fujiyuki; Shunsuke Numata; Xiao Han; Kazuaki Obata; Setsuo Hasegawa; Hiroki Yamaguchi; Koiti Inokuchi; Teruyo Ito; Keiichi Hiramatsu; Kazuhisa Sekimizu
Journal:  PLoS Pathog       Date:  2013-04-04       Impact factor: 6.823

10.  Characteristics of invasive Staphylococcus aureus infections in three regions of Korea, 2009-2011: a multi-center cohort study.

Authors:  Kyoung-Ho Song; Eu Suk Kim; Hye-Yun Sin; Kyung-Hwa Park; Sook-In Jung; Nara Yoon; Dong-Min Kim; Chang Seop Lee; Hee-Chang Jang; Yoonseon Park; Kkot Sil Lee; Yee Gyung Kwak; Jae Hoon Lee; Seong Yeon Park; Minkyo Song; Sue K Park; Yeong-Seon Lee; Hong Bin Kim
Journal:  BMC Infect Dis       Date:  2013-12-10       Impact factor: 3.090

View more
  13 in total

1.  agr functionality affects clinical outcomes in patients with persistent methicillin-resistant Staphylococcus aureus bacteraemia.

Authors:  C K Kang; Y K Kim; S-I Jung; W B Park; K-H Song; K-H Park; P G Choe; H-C Jang; S Lee; Y-S Kim; Y G Kwak; K T Kwon; S Kiem; C-J Kim; E S Kim; H B Kim
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2017-06-21       Impact factor: 3.267

2.  Characteristics of the community-genotype sequence type 72 methicillin-resistant Staphylococcus aureus isolates that underlie their persistence in hospitals.

Authors:  Eun-Jeong Joo; Ji-Young Choi; Doo Ryeon Chung; Jae-Hoon Song; Kwan Soo Ko
Journal:  J Microbiol       Date:  2016-05-27       Impact factor: 3.422

Review 3.  Virulence Factor Targeting of the Bacterial Pathogen Staphylococcus aureus for Vaccine and Therapeutics.

Authors:  Trevor L Kane; Katelyn E Carothers; Shaun W Lee
Journal:  Curr Drug Targets       Date:  2018       Impact factor: 3.465

4.  A Prospective Cohort Study of Durations of Staphylococcus aureus Bacteremia According to Different Phenotypes and a New Concept of Persistent Bacteremia.

Authors:  Chang Kyung Kang; Kyoung-Ho Song; Seong Eun Kim; Eu Suk Kim; Wan Beom Park; Kyung-Hwa Park; Shin Hye Chun; Shinwon Lee; Chong Rae Cho; Seung Ji Kang; Myoung-Don Oh; Yeon-Sook Kim; Sun Hee Lee; Yee Gyung Kwak; Hee-Chang Jang; Chung-Jong Kim; Young Keun Kim; Ji-Hwan Bang; Sungmin Kiem; Ki Tae Kwon; Younghee Jung; Yu Min Kang; Sook-In Jung; Hong Bin Kim
Journal:  Antimicrob Agents Chemother       Date:  2019-12-20       Impact factor: 5.191

5.  Clinical impact of and microbiological risk factors for qacA/B positivity in ICU-acquired ST5-methicillin-resistant SCCmec type II Staphylococcus aureus bacteremia.

Authors:  Haein Kim; Sunghee Park; Hyeonji Seo; Hyemin Chung; Eun Sil Kim; Heungsup Sung; Mi-Na Kim; Seongman Bae; Jiwon Jung; Min Jae Kim; Sung-Han Kim; Sang-Oh Lee; Sang-Ho Choi; Yang Soo Kim; Yong Pil Chong
Journal:  Sci Rep       Date:  2022-07-06       Impact factor: 4.996

6.  Decreased Incidence of Methicillin-Resistant Staphylococcus aureus Bacteremia in Intensive Care Units: a 10-Year Clinical, Microbiological, and Genotypic Analysis in a Tertiary Hospital.

Authors:  Haein Kim; Eun Sil Kim; Seung Cheol Lee; Eunmi Yang; Hee Sueng Kim; Heungsup Sung; Mi-Na Kim; Jiwon Jung; Min Jae Kim; Sung-Han Kim; Sang-Oh Lee; Sang-Ho Choi; Jun Hee Woo; Yang Soo Kim; Yong Pil Chong
Journal:  Antimicrob Agents Chemother       Date:  2020-09-21       Impact factor: 5.191

Review 7.  Staphylococcus aureus bloodstream infections: pathogenesis and regulatory mechanisms.

Authors:  Jakub M Kwiecinski; Alexander R Horswill
Journal:  Curr Opin Microbiol       Date:  2020-03-12       Impact factor: 7.934

8.  Distribution of SCCmec Elements and Presence of Panton-Valentine Leukocidin in Methicillin-Resistant Staphylococcusepidermidis Isolated from Clinical Samples in a University Hospital of Isfahan City, Iran.

Authors:  Mehrdad Halaji; Ashkan Karimi; Parisa Shoaei; Mohammadreza Nahaei; Farzin Khorvash; Behrooz Ataei; Majid Yaran; Seyed Asghar Havaei
Journal:  J Clin Diagn Res       Date:  2017-07-01

9.  Impact of Community-Onset Methicillin-Resistant Staphylococcus aureus on Staphylococcus aureus Bacteremia in a Central Korea Veterans Health Service Hospital.

Authors:  Eunsin Bae; Choon Kwan Kim; Jung Hyun Jang; Heungsup Sung; YounMi Choi; Mi Na Kim
Journal:  Ann Lab Med       Date:  2019-03       Impact factor: 3.464

10.  Naturally occurring polymorphisms in the virulence regulator Rsp modulate Staphylococcus aureus survival in blood and antibiotic susceptibility.

Authors:  Aishwarya Krishna; Matthew T G Holden; Sharon J Peacock; Andrew M Edwards; Sivaramesh Wigneshweraraj
Journal:  Microbiology (Reading)       Date:  2018-07-20       Impact factor: 2.777

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.